James E. Muller is an American cardiologist and medical device executive.
He was a member of the faculty of Harvard Medical School for over 25 years, where he studied triggers of coronary artery plaque rupture and sudden cardiac death.
He is Founder, Chief Medical Officer, and chairman of the Board[2] of InfraReDx, Inc. which manufactures a catheter-based near-infrared spectroscopy system used to identify cholesterol rich plaques in patients undergoing cardiac catheterization.
This system was cleared by the U.S. Food and Drug Administration[3] for use to identify lipid core in coronary plaques of interest.
This biographical article related to a physician in the United States is a stub.